Semi-Annual Statement Of Income

TORII PHARMACEUTICAL CO., LTD. - Filing #7271627

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Semi-annual statement of income
Statement of income
Net sales
60,426,000,000 JPY
54,638,000,000 JPY
Cost of sales
33,719,000,000 JPY
29,847,000,000 JPY
Ordinary profit (loss)
6,926,000,000 JPY
5,307,000,000 JPY
Gross profit (loss)
26,707,000,000 JPY
24,791,000,000 JPY
Extraordinary income
JPY
349,000,000 JPY
Selling, general and administrative expenses
19,908,000,000 JPY
19,755,000,000 JPY
Extraordinary losses
200,000,000 JPY
63,000,000 JPY
Selling, general and administrative expenses
Depreciation
202,000,000 JPY
218,000,000 JPY
Profit (loss) before income taxes
6,725,000,000 JPY
5,593,000,000 JPY
Operating profit (loss)
6,798,000,000 JPY
5,035,000,000 JPY
Income taxes - current
1,619,000,000 JPY
1,824,000,000 JPY
Non-operating income
486,000,000 JPY
421,000,000 JPY
Non-operating income
Interest income
4,000,000 JPY
0 JPY
Interest on securities
353,000,000 JPY
287,000,000 JPY
Dividend income
106,000,000 JPY
112,000,000 JPY
Income taxes - deferred
63,000,000 JPY
-350,000,000 JPY
Income taxes
1,682,000,000 JPY
1,473,000,000 JPY
Non-operating expenses
358,000,000 JPY
149,000,000 JPY
Profit (loss)
5,042,000,000 JPY
5,042,000,000 JPY
5,042,000,000 JPY
5,042,000,000 JPY
4,119,000,000 JPY
4,119,000,000 JPY
4,119,000,000 JPY
4,119,000,000 JPY
Non-operating expenses
Interest expenses
0 JPY
0 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.